Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Non-Current Liabilities (2020 - 2024)

Journey Medical filings provide 5 years of Total Non-Current Liabilities readings, the most recent being $60.2 million for Q4 2024.

  • On a quarterly basis, Total Non-Current Liabilities rose 6.5% to $60.2 million in Q4 2024 year-over-year; TTM through Dec 2024 was $60.2 million, a 6.5% increase, with the full-year FY2024 number at $60.2 million, up 6.5% from a year prior.
  • Total Non-Current Liabilities hit $60.2 million in Q4 2024 for Journey Medical, up from $56.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $97.2 million in Q3 2021 to a low of $33.5 million in Q4 2020.
  • Median Total Non-Current Liabilities over the past 5 years was $74.9 million (2022), compared with a mean of $70.2 million.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 68.11% in 2022 and later crashed 34.88% in 2023.
  • Journey Medical's Total Non-Current Liabilities stood at $33.5 million in 2020, then surged by 54.18% to $51.6 million in 2021, then surged by 68.11% to $86.8 million in 2022, then plummeted by 34.88% to $56.5 million in 2023, then increased by 6.5% to $60.2 million in 2024.
  • The last three reported values for Total Non-Current Liabilities were $60.2 million (Q4 2024), $56.5 million (Q4 2023), and $68.3 million (Q2 2023) per Business Quant data.